Literature DB >> 24225204

Italian registry of cardiac magnetic resonance.

Marco Francone1, Ernesto Di Cesare2, Filippo Cademartiri3, Gianluca Pontone4, Luigi Lovato5, Gildo Matta6, Francesco Secchi7, Erica Maffei3, Silvia Pradella8, Iacopo Carbone1, Riccardo Marano9, Lorenzo Bacigalupo10, Elisabetta Chiodi11, Rocco Donato12, Stefano Sbarbati13, Francesco De Cobelli14, Paolo di Renzi15, Guido Ligabue, Andrea Mancini, Francesco Palmierir, Gennaro Restaino, Giovanni Puppini, Maurizio Centonze, Wiliam Toscano, Carlo Tessa, Riccardo Faletti, Massimo Conti, Arnaldo Scardapane, Salvatore Galea, Carlo Liguori, Marzio Pagliacci, Domenico Lumia, Marco di Girolamo, Andrea Romagnoli, Alessandro Guarise, Stefano Cirillo, Biagio Gagliardi, Claudia Borghi, Matteo Quarenghi, Franco Contin, Fiorenzo Scaranello, Armando Tartaro, Carlo Marinucci, Lorenzo Monti.   

Abstract

OBJECTIVES: Forty sites were involved in this multicenter and multivendor registry, which sought to evaluate indications, spectrum of protocols, impact on clinical decision making and safety profile of cardiac magnetic resonance (CMR).
MATERIALS AND METHODS: Data were prospectively collected on a 6-month period and included 3376 patients (47.2 ± 19 years; range 1-92 years). Recruited centers were asked to complete a preliminary general report followed by a single form/patient. Referral physicians were not required to exhibit any specific certificate of competency in CMR imaging.
RESULTS: Exams were performed with 1.5T scanners in 96% of cases followed by 3T (3%) and 1T (1%) magnets and contrast was administered in 84% of cases. The majority of cases were performed for the workup of inflammatory heart disease/cardiomyopathies representing overall 55.7% of exams followed by the assessment of myocardial viability and acute infarction (respectively 6.9% and 5.9% of patients). In 49% of cases the final diagnosis provided was considered relevant and with impact on patient's clinical/therapeutic management. Safety evaluation revealed 30 (0.88%) clinical events, most of which due to patient's preexisting conditions. Radiological reporting was recorded in 73% of exams.
CONCLUSIONS: CMR is performed in a large number of centers in Italy with relevant impact on clinical decision making and high safety profile.
Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Acquisition protocols; CAD; CMP; CMR; CMR-registry; Clinical indications; Italian Society of Medical Radiology; Patient's management; SIRM; Safety profile; cardiac magnetic resonance; cardiomyopathy; coronary artery disease

Mesh:

Year:  2013        PMID: 24225204     DOI: 10.1016/j.ejrad.2013.10.006

Source DB:  PubMed          Journal:  Eur J Radiol        ISSN: 0720-048X            Impact factor:   3.528


  12 in total

1.  Cardiac-CT and Cardiac-MR examinations cost analysis, based on data of four Italian Centers.

Authors:  Maurizio Centonze; Giuseppe Lorenzin; Andrea Francesconi; Filippo Cademartiri; Giulia Casagranda; Michele Fusaro; Guido Ligabue; Giovanna Zanetti; Demetrio Spanti; Francesco De Cobelli
Journal:  Radiol Med       Date:  2015-07-26       Impact factor: 3.469

2.  Intra- and inter-reader reproducibility of blood flow measurements on the ascending aorta and pulmonary artery using cardiac magnetic resonance.

Authors:  Giovanni Di Leo; Ida Daniela D'Angelo; Marco Alì; Paola Maria Cannaò; Giovanni Mauri; Francesco Secchi; Francesco Sardanelli
Journal:  Radiol Med       Date:  2016-11-22       Impact factor: 3.469

3.  Clinical and magnetic resonance evolution of "infarct-like" myocarditis.

Authors:  Riccardo Faletti; Marco Gatti; Ilaria Baralis; Laura Bergamasco; Rodolfo Bonamini; Francesca Ferroni; Massimo Imazio; Silvia Stola; Fiorenzo Gaita; Paolo Fonio
Journal:  Radiol Med       Date:  2017-01-09       Impact factor: 3.469

4.  Assessment of acute myocarditis by cardiac magnetic resonance imaging: Comparison of qualitative and quantitative analysis methods.

Authors:  Massimo Imbriaco; Carmela Nappi; Marta Puglia; Marco De Giorgi; Serena Dell'Aversana; Renato Cuocolo; Andrea Ponsiglione; Igino De Giorgi; Maria Vincenza Polito; Michele Klain; Federico Piscione; Leonardo Pace; Alberto Cuocolo
Journal:  J Nucl Cardiol       Date:  2017-10-26       Impact factor: 5.952

5.  Lights and shadows of cardiac magnetic resonance imaging in acute myocarditis.

Authors:  Antonio Esposito; Marco Francone; Riccardo Faletti; Maurizio Centonze; Filippo Cademartiri; Iacopo Carbone; Roberto De Rosa; Ernesto Di Cesare; Ludovico La Grutta; Guido Ligabue; Luigi Lovato; Erica Maffei; Riccardo Marano; Massimo Midiri; Gianluca Pontone; Luigi Natale; Francesco De Cobelli
Journal:  Insights Imaging       Date:  2015-11-10

6.  CT and MR imaging of the thoracic aorta.

Authors:  Ernesto Di Cesare; Alessandra Splendiani; Antonio Barile; Ettore Squillaci; Annamaria Di Cesare; Luca Brunese; Carlo Masciocchi
Journal:  Open Med (Wars)       Date:  2016-06-23

7.  Diagnostic value/performance of radiological liver imaging during chemoterapy for gastrointestinal malignancy: a critical review.

Authors:  Alfonso Reginelli; Giovanna Vacca; Nicoletta Zanaletti; Teresa Troiani; Raffaele Natella; Nicola Maggialetti; Pierpaolo Palumbo; Andrea Giovagnoni; Fortunato Ciardiello; Salvatore Cappabianca
Journal:  Acta Biomed       Date:  2019-04-24

8.  Advances in diagnostic and interventional radiology.

Authors:  Massimo De Filippo; Luca Brunese; Alfonso Reginelli
Journal:  Acta Biomed       Date:  2019-04-24

Review 9.  Radiological Cardiothoracic Ratio in Evidence-Based Medicine.

Authors:  Krystian Truszkiewicz; Rafał Poręba; Paweł Gać
Journal:  J Clin Med       Date:  2021-05-08       Impact factor: 4.241

Review 10.  The Prognostic Importance of Right Ventricular Longitudinal Strain in Patients with Cardiomyopathies, Connective Tissue Diseases, Coronary Artery Disease, and Congenital Heart Diseases.

Authors:  Marijana Tadic; Johannes Kersten; Nicoleta Nita; Leonhard Schneider; Dominik Buckert; Birgid Gonska; Dominik Scharnbeck; Tilman Dahme; Armin Imhof; Evgeny Belyavskiy; Cesare Cuspidi; Wolfgang Rottbauer
Journal:  Diagnostics (Basel)       Date:  2021-05-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.